undefined
EUTM file information

018494703

ADARE PHARMA SOLUTIONS


June 15, 2021

Trademark Summary

The trademark application ADARE PHARMA SOLUTIONS was filed by ADARE PHARMACEUTICALS, INC., a U.S. corporation (the "Applicant"). The application was published for oppositions on July 12, 2021, and it was registered by office on October 19, 2021 without any oppositions.

The application was filed in English (Italian was selected as the second language).

Change of name and professional address of the trademark registration was recorded on May 16, 2023.


Goods And Services

  • The mark was filed in class 40 with following description of goods:
    1. Manufacturing of medical and pharmaceutical products and formulations, nutritional and dietary formulations, to the specification of others, comprising bacterial strains or heat treated bacterial strains or inactivated bacterial strains
    2. Manufacturing of drug delivery products for the immediate, controlled, extended, delayed, pulsatile or local release of a therapeutic, nutritional or dietary agent
    3. Manufacturing of pharmaceutical and dietary compositions for use in veterinary administration forms such as tablets, capsules, suspensions, liquids
    4. Manufacturing of particles with specific particle dimension and narrow particle size distributions containing active ingredients.
  • The mark was filed in class 42 with following description of goods:
    1. Design and development of pharmaceutical, nutritional and dietary formulations
    2. Research and development of drug delivery formulation used as facilitating agents for pharmaceutical tablets, capsules, powders, injectables, suspensions, gels, liquids
    3. Development of formulations for veterinary applications
    4. Design and development of medical and pharmaceutical preparations in liquid form or solid form for the immediate, controlled, extended, delayed, pulsatile or local release of a therapeutic or dietary agent
    5. Development of particles with defined particle size dimensions and particle size distribution containing active ingredients
    6. Technology consultation in the field of pharmaceutical development
    7. Review of material for promotional documents and campaign in the field of pharmaceutical development.